Kalfa, D., Rajab, T. K., Cordoves, E., Emani, S., Bacha, E., Jaggers, J., … Turek, J. (2024). Living allogenic heart valve transplantation: Relative advantages and unanswered questions. J Thorac Cardiovasc Surg, 167(5), 1543–1546. https://doi.org/10.1016/j.jtcvs.2023.09.036

Kalfa, David, Taufiek K. Rajab, Elizabeth Cordoves, Sitaram Emani, Emile Bacha, James Jaggers, Andrew Goldstone, Pirooz Eghtesady, and Joseph Turek. “Living allogenic heart valve transplantation: Relative advantages and unanswered questions.” J Thorac Cardiovasc Surg 167, no. 5 (May 2024): 1543–46. https://doi.org/10.1016/j.jtcvs.2023.09.036.

Kalfa D, Rajab TK, Cordoves E, Emani S, Bacha E, Jaggers J, et al. Living allogenic heart valve transplantation: Relative advantages and unanswered questions. J Thorac Cardiovasc Surg. 2024 May;167(5):1543–6.

Kalfa, David, et al. “Living allogenic heart valve transplantation: Relative advantages and unanswered questions.” J Thorac Cardiovasc Surg, vol. 167, no. 5, May 2024, pp. 1543–46. Pubmed, doi:10.1016/j.jtcvs.2023.09.036.

Kalfa D, Rajab TK, Cordoves E, Emani S, Bacha E, Jaggers J, Goldstone A, Eghtesady P, Turek J. Living allogenic heart valve transplantation: Relative advantages and unanswered questions. J Thorac Cardiovasc Surg. 2024 May;167(5):1543–1546.